title: Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis.
authors.affiliation: Department of Dermatology, Hamamatsu University School of Medicine, Shizuoka, Japan. Electronic address: itoutai@hama-med.ac.jp.
authors.forename: Taisuke
authors.initials: T
authors.lastname: Ito
authors.affiliation: Department of Dermatology, Hamamatsu University School of Medicine, Shizuoka, Japan.
authors.forename: Kazuki
authors.initials: K
authors.lastname: Tatsuno
authors.affiliation: Department of Dermatology, Hamamatsu University School of Medicine, Shizuoka, Japan.
authors.forename: Jun-Ichi
authors.initials: J
authors.lastname: Sakabe
authors.affiliation: Department of Dermatology, Hamamatsu University School of Medicine, Shizuoka, Japan.
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Fujiyama
authors.affiliation: Department of Dermatology, Hamamatsu University School of Medicine, Shizuoka, Japan.
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Tokura
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000502:physiology; D002478:Cells, Cultured; D054414:Chemokine CCL17 / Q000276:immunology*; D002633:Chemotaxis / Q000187:drug effects; D003876:Dermatitis, Atopic / Q000276:immunology*; D006633:Histamine Antagonists / Q000494:pharmacology*; D006801:Humans; D000069605:Olopatadine Hydrochloride / Q000494:pharmacology*
chemical_list: C106230:CCL17 protein, human; D054414:Chemokine CCL17; D006633:Histamine Antagonists; D000069605:Olopatadine Hydrochloride